188 related articles for article (PubMed ID: 8638026)
21. Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias.
Saksena S; Madan N; Lewis C
Prog Cardiovasc Dis; 1996; 38(6):445-54. PubMed ID: 8638025
[TBL] [Abstract][Full Text] [Related]
22. Advances in the pharmacologic treatment of ventricular arrhythmias.
Schleifer JW; Sorajja D; Shen WK
Expert Opin Pharmacother; 2015; 16(17):2637-51. PubMed ID: 26513538
[TBL] [Abstract][Full Text] [Related]
23. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
[TBL] [Abstract][Full Text] [Related]
24. Class III antiarrhythmic drugs.
Singh BN; Ahmed R
Curr Opin Cardiol; 1994 Jan; 9(1):12-22. PubMed ID: 8199363
[TBL] [Abstract][Full Text] [Related]
25. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
Anderson JL
J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
[TBL] [Abstract][Full Text] [Related]
26. Results of Holter ECG guided therapy for ventricular arrhythmias: the ESVEM trial.
Lazzara R
Pacing Clin Electrophysiol; 1994 Mar; 17(3 Pt 2):473-7. PubMed ID: 7513876
[TBL] [Abstract][Full Text] [Related]
27. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
Connolly SJ; Dorian P; Roberts RS; Gent M; Bailin S; Fain ES; Thorpe K; Champagne J; Talajic M; Coutu B; Gronefeld GC; Hohnloser SH;
JAMA; 2006 Jan; 295(2):165-71. PubMed ID: 16403928
[TBL] [Abstract][Full Text] [Related]
28. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
Mitchell LB
J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
[No Abstract] [Full Text] [Related]
29. [Drug therapy of ventricular arrhythmias].
Hohnloser SH
Med Klin (Munich); 1997 Apr; 92(4):208-10. PubMed ID: 9221302
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.
Marcus GM; Glidden DV; Polonsky B; Zareba W; Smith LM; Cannom DS; Estes NA; Marcus F; Scheinman MM;
J Am Coll Cardiol; 2009 Aug; 54(7):609-15. PubMed ID: 19660690
[TBL] [Abstract][Full Text] [Related]
31. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
Campbell RW; Furniss SS
Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
[TBL] [Abstract][Full Text] [Related]
32. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
33. A summary and assessment of the findings and conclusions of the ESVEM trial.
Mason JW; Marcus FI; Bigger JT; Lazzara R; Reiffel JA; Reiter MJ; Mann D
Prog Cardiovasc Dis; 1996; 38(5):347-58. PubMed ID: 8604439
[TBL] [Abstract][Full Text] [Related]
34. Comparison of sotalol with amiodarone for long-term treatment of spontaneous sustained ventricular tachyarrhythmia based on coronary artery disease.
Kovoor P; Eipper V; Byth K; Cooper MJ; Uther JB; Ross DL
Eur Heart J; 1999 Mar; 20(5):364-74. PubMed ID: 10206383
[TBL] [Abstract][Full Text] [Related]
35. Drugs for ventricular arrhythmias in the era of the implantable cardioverter defibrillator.
Peters NS
Eur Heart J; 1999 Mar; 20(5):321-3. PubMed ID: 10206376
[No Abstract] [Full Text] [Related]
36. Effects of sotalol and d-sotalol on ventricular tachycardia and fibrillation induced by programmed electrical stimulation.
Aliot E; Sadoul N; De Chillou C
Eur Heart J; 1993 Nov; 14 Suppl H():74-7. PubMed ID: 7904940
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive therapy for recurrent ventricular tachycardia in patients with implantable cardioverter defibrillators.
Reiffel JA
Curr Cardiol Rep; 2007 Sep; 9(5):381-6. PubMed ID: 17877933
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of antiarrhythmic therapy in dogs with naturally acquired tachyarrhythmias treated with amiodarone or sotalol: a retrospective analysis of 64 cases.
Romito G; Gemma N; Dondi F; Mazzoldi C; Fasoli S; Cipone M
J Vet Cardiol; 2024 Jun; 53():20-35. PubMed ID: 38608438
[TBL] [Abstract][Full Text] [Related]
39. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
Ohnishi S; Kasanuki H
J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
[TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic drugs and devices for the management of ventricular tachyarrhythmia in ischemic heart disease.
Reiffel JA; Reiter MJ; Blitzer M
Am J Cardiol; 1998 Aug; 82(4A):31I-40I. PubMed ID: 9737652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
